TGpeptide

Nanjing TGpeptide Biotechnology Co., Ltd. (TGpeptide) is a high-tech biotechnology company based in Nanjing, China, specializing in the research, development, and manufacturing of peptides, antibodies, and proteins. Founded in 2019, the company provides a comprehensive suite of services including custom peptide synthesis, small molecule synthesis, and antibody production for pharmaceutical companies and research institutes globally. TGpeptide is particularly recognized for its expertise in synthesizing long and complex peptides, offering over 400 types of modifications and a diverse catalog of more than 2,000 peptides. Their proprietary peptide library technology serves as a robust platform for high-throughput drug screening and the identification of protein-protein interactions. The company operates a 1,400-square-meter facility equipped with advanced analytical and manufacturing instruments, ensuring high-quality standards for its products and services.